These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18938694)

  • 1. [Adipocentrism and cardiovascular risk].
    Trejo Gutiérrez JF
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-34-8. PubMed ID: 18938694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular risk and metabolic syndrome in youth: Canadian perspectives].
    Lambert M
    Arch Pediatr; 2009 Jun; 16(6):689-91. PubMed ID: 19541131
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic syndrome and cardiovascular disease.
    Waspadji S
    Acta Med Indones; 2006; 38(4):177-8. PubMed ID: 17175608
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular risk associated with obesity and metabolic syndrome: the European point of view].
    Tounian P
    Arch Pediatr; 2009 Jun; 16(6):687-8. PubMed ID: 19541130
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differences between women and men: even through cardiovascular risk factors... role of the gynecologist].
    Berdah J; Amah G
    Gynecol Obstet Fertil; 2009 Feb; 37(2):186-93. PubMed ID: 19211291
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of metabolic syndrome and cardiovascular risk among police personnel compared to general population in India.
    Tharkar S; Kumpatla S; Muthukumaran P; Viswanathan V
    J Assoc Physicians India; 2008 Nov; 56():845-9. PubMed ID: 19263681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of tobacco smoke exposure and metabolic syndrome on cardiovascular risk in older residents of China.
    He Y; Lam TH; Jiang B; Wang J; Sai X; Fan L; Li X; Qin Y; Hu FB
    J Am Coll Cardiol; 2009 Jan; 53(4):363-71. PubMed ID: 19161888
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic syndrome as cardiovascular risk factor].
    Dłuzniewski M; Mamcarz A
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II28-9. PubMed ID: 19813332
    [No Abstract]   [Full Text] [Related]  

  • 12. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
    Frohlich ED
    J Cardiometab Syndr; 2008; 3(3):147-8. PubMed ID: 18983330
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and the urological patient.
    Kirby M; Kirby R
    BJU Int; 2009 Nov; 104(9):1185-6. PubMed ID: 19583722
    [No Abstract]   [Full Text] [Related]  

  • 17. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.
    Kelishadi R; Gharipour M; Sadri GH; Tavasoli AA; Amani A
    East Mediterr Health J; 2008; 14(5):1070-9. PubMed ID: 19161079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.